This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311)

Published on in Vol 5, No 3 (2016): Jul-Sept

Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study

Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study

Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study

Authors of this article:

Poobalan Naidoo1 Author Orcid Image ;   Jeffrey Wing1 Author Orcid Image ;   Virendra Rambiritch2 Author Orcid Image
Article Authors Cited by (12) Tweetations (2) Metrics

Journals

  1. Hemmingsen B, Sonne D, Metzendorf M, Richter B. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2017;2017(5) View
  2. Boeva V, Zavyalov A. Preventive pharmacotherapy of type 2 diabetes mellitus in patients with early carbohydrate metabolism disorders: long-term efficacy and clinical outcomes. Bulletin of Russian State Medical University 2020;((2)2020) View
  3. Guida C, Stephen S, Guitton R, Ramracheya R. The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes. Trends in Endocrinology & Metabolism 2017;28(8):626 View
  4. Ryuk J, Lixia M, Cao S, Ko B, Park S. Efficacy and safety of Gegen Qinlian decoction for normalizing hyperglycemia in diabetic patients: A systematic review and meta-analysis of randomized clinical trials. Complementary Therapies in Medicine 2017;33:6 View
  5. Mangan A, Docherty N, Le Roux C, Al-Najim W. Current and emerging pharmacotherapy for prediabetes: are we moving forward?. Expert Opinion on Pharmacotherapy 2018;19(15):1663 View
  6. Kisnawaty S, Nityasewaka P, Sukma B, Putrinadia A, Ma’rifah T, Tamtomo D, Indarto D. Alkaloid Fraction of Litsea glutinosa Leaves Provides an Important Precursor for Inhibition of Dipeptidyl Peptidase 4 Activity. IOP Conference Series: Materials Science and Engineering 2019;546(6):062013 View
  7. Cahn A, Cernea S, Raz I. An update on DPP-4 inhibitors in the management of type 2 diabetes. Expert Opinion on Emerging Drugs 2016;21(4):409 View
  8. Farr O, Mantzoros C. Treatment options to prevent diabetes in subjects with prediabetes: Efficacy, cost effectiveness and future outlook. Metabolism 2017;70:192 View
  9. Sokolova L, Pushkarev V, Kovzun O. Механізми дії метформіну за діабету та пов’язаних із діабетом патологій. Endokrynologia 2020;25(2):143 View
  10. Sokolova L, Pushkarev V, Tronko M. Предіабет і метаболічний синдром. Характеристика і маркери. Endokrynologia 2021;26(2):179 View

Books/Policy Documents

  1. Yan Y, L. Kover K, V. Moore W. Metformin [Working Title]. View
  2. Singh A, Singh R. Metabolic Syndrome. View